Trump signs order to accelerate access to psychedelic drug treatments

Former President Donald Trump has signed an executive order aimed at accelerating access to psychedelic drug treatments for mental health conditions. The order directs federal agencies to streamline research and regulatory pathways for substances like psilocybin and MDMA. The administration says the move could make these therapies available to patients by 2026.